GRANIX (Cephalon, Inc.)


Welcome to the PulseAid listing for the GRANIX drug offered from Cephalon, Inc.. This Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cephalon, Inc.
NON-PROPRIETARY NAME: tbo-filgrastim
SUBSTANCE NAME: FILGRASTIM, LICENSE HOLDER UNSPECIFIED
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2013-11-11
END MARKETING DATE: 0000-00-00


GRANIX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGRANIX from Cephalon, Inc.
LABELER NAME: Cephalon, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 300(ug/.5mL)
START MARKETING DATE: 2013-11-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63459-910_88691ecb-49f0-442c-b66a-a144d9587e50
PRODUCT NDC: 63459-910
APPLICATION NUMBER: BLA125294

Other FILGRASTIM, LICENSE HOLDER UNSPECIFIED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cephalon, Inc.GRANIX
Sandoz IncZARXIO